00068-7/asset/096c9be0-b6df-496c-ad71-95f35e424b2e/main.assets/gr2_lrg.jpg)
semaglutide and cirrhosis 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial Wegovy (semaglutide) for fatty liver
Description
Voor mensen met een verminderde nierfunctie kan uitdroging extra gevaarlijk zijn
Many patients report that alcohol tolerance drops on semaglutide, meaning smaller amounts cause disproportionate effects
Use your best judgment
The weight loss trajectory of this medication suggests that moderate sleep apnea may resolve entirely for many users, while severe cases may see substantial enough improvement to reduce CPAP pressure requirements or allow alternative, less cumbersome therapies
